Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06932289 · ClinicalTrials.gov registry record · NA
Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions
A NA study, sponsored by VA Greater Los Angeles Healthcare System.
- Not yet
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT06932289 is a NA study that has not yet begun recruiting, run by VA Greater Los Angeles Healthcare System. The registered enrollment target is 54 participants.
The verdict
NCT06932289, a NA study, has not yet begun recruiting, sponsored by VA Greater Los Angeles Healthcare System.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
It is a 12-week study. The participants will follow three different diets, and during each diet period, and the participants will wear our device, and blood samples will be collected.
Interventions
- DIETARY_SUPPLEMENT Mediterranean diet (MED), high-fat/low carb diet (HF/LC), and low-fat diet (LF)
- DEVICE The integrated sweat sensor and vascular sensor (wearable)
- DEVICE continuous glucose monitor (CGM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2029-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06932289
The ClinicalTrials.gov registry entry for NCT06932289 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Greater Los Angeles Healthcare System, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Mediterranean diet (MED), high-fat/low carb diet (HF/LC), and low-fat diet (LF) is the first listed.
NCT06932289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06932289 about?
NCT06932289 is a clinical study titled "Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions". It is a 12-week study. The participants will follow three different diets, and during each diet period, and the participants will wear our device, and blood samples will be collected.
What is the current status of trial NCT06932289?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 54 participants. The study started on 2025-05-01. Estimated completion is 2029-05-01.
What interventions are being tested in trial NCT06932289?
The interventions under investigation include: Mediterranean diet (MED), high-fat/low carb diet (HF/LC), and low-fat diet (LF) (DIETARY_SUPPLEMENT), The integrated sweat sensor and vascular sensor (wearable) (DEVICE), continuous glucose monitor (CGM) (DEVICE).
Who is sponsoring clinical trial NCT06932289?
This trial is sponsored by VA Greater Los Angeles Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.